Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples